MD Anderson Cancer Center

Huston, Texas 77030

1 studies enrolling now · 2 studies all time

What they study most

AML/MDS, CMML, Chronic Myelomonocytic Leukemia, Leukemia, Myeloid, Acute, Myelodysplastic Syndrome With Excess Blasts-2, Refractory AML, Refractory Acute Lymphoblastic Leukemia, Relapse, Relapse Leukemia, Relapsed Adult AML

Studies at this site

• Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
• Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML — Completed